Brief: SAB Biotherapeutics Enters Sales Agreement With UBS Securities - SEC Filing
29/12/2025 23:01
Dec 29 (Reuters) - SAB Biotherapeutics Inc SABS.O: SAB BIOTHERAPEUTICS INC - ENTERS SALES AGREEMENT WITH UBS SECURITIES - SEC FILING SAB BIOTHERAPEUTICS INC - CO MAY OFFER AND SELL FROM TIME TO TIME COMMON STOCK OF UP TO $75 MILLION - SEC FILING Source text: [ID:n0001193125-25-335267] Further company coverage: SABS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies